Bain and Cinven get Stada at second attempt

21 August 2017 - Deborah Wilkes


Private-equity firms Bain Capital and Cinven have succeeded in their second attempt to acquire German generics and OTC company Stada Arzneimittel. Supraj Rajagopalan and Bruno Schick, partners at Cinven, said the firm was "committed to adding significant value to Stada including investment in organic growth and expansion through acquisitions".

Click tags below for more information on topics:


Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: